Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04056208Phase 2Completed
Phase 2, randomised, open-label trial in prediabetes, sponsored by The Pennsylvania State University. Primary endpoint: Fasting plasma glucose concentration at 12 weeks. Started Sep 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04056208.